Argenics: Vivgard Hytrulo Pre-Filled Syringe, which contains F-Gartigamide Alpha and… · Jul 10–29, 2026

New
Argenics

The campaign promoted the Vivgard Hytrulo Pre-Filled Syringe, which contains F-Gartigamide Alpha and Hyaluronidase QVFC, by emphasizing the convenience and personal control of self-injecting treatment on one's own terms.

Jul 10, 2026
First seen
Jul 29, 2026
Last seen
3
Reads
3
Shows
1
Active months
33s
Avg. length

13-week activity

Public campaign reads by observed week

through Aug 3
1
1
1

Renewal signals

30 dayPending
60 dayPending
90 dayPending
Promo-code persistence

No recurring promo code was observed.

Core offer

Vivgard Hytrulo Pre-Filled Syringe, which contains F-Gartigamide Alpha and Hyaluronidase QVFC

Creative angle

convenience and personal control

Representative reads

Examples across the campaign

Example transcript

The read that best represents this campaign's recurring script

View promo
Get Up·Hour 1: Kawhi Deal Unraveling, LeBron's Voice Notes, NBA Top Picks Battle
Est. value ~$240range $36$1.7Klow confidence
I like things my way, my coffee, my schedule, and my treatment. So I talked to my doctor about self-injecting with the Vivgard Hytrulo Pre-Filled Syringe, which contains F-Gartigamide Alpha and Hyaluronidase QVFC. It's injected under your skin subcutaneously. It means I can inject in my space on my time. It's my treatment, my way. Visit VivGuardMyWay.com. That's V-Y-V-G-A-R-T MyWay.com. And talk to your doctor about VivGuard Hattrulo. Brought to you by Argenics.

More campaigns from Argenics

Other published campaigns from this sponsor

View all

These signals describe observed podcast advertising activity. Per-read dollar figures are directional current placement proxies—not historical campaign spend, reach, conversions, or return on investment.